Study finds no link between fluoride and osteosarcoma
There is no significant association between bone fluoride levels and osteosarcoma risk, according to a new study in the Journal of Dental Research (July 28,
There is no significant association between bone fluoride levels and osteosarcoma risk, according to a new study in the Journal of Dental Research (July 28,
SECAUCUS, NJ – July 8, 2011- Vatech America, Inc., the world’s leading developer of digital dental radiography & Cone Beam CT systems, software and services,
The British Dental Trade Association (BDTA) is heralding the opportunities of the UK healthcare industry, particularly in dental care, while pointing out the need to
LED Dental has released a camera system to complement VELscope Vx, designed to help detect and document abnormal mucosal tissue. After shining the VELscope’s blue
Cedars-Sinai Hospital’s COACH for Kids and Their Families mobile medical program has been selected as one of 20 U.S. school-based programs to receive a $15,000
MuGard, a novel treatment for oral mucositis developed by Access Pharmaceuticals, is now being covered by Tricare, the U.S. military health plan. Tricare covers more
Cancer Research U.K. has launched a large, multicenter trial to test a new device for detecting Barrett’s esophagus, a condition that puts sufferers at increased
There’s a pervasive problem in restorative dentistry, according to a new study in the Journal of the American Dental Association (July 2011, Vol. 142:7, pp.
Heraeus Kulzer has made a commitment to help victims of domestic violence through the American Academy of Cosmetic Dentistry (AACD) Charitable Foundation’s Give Back A
In response to concerns over the degradation of titanium implants, researchers from the University of Oviedo in Spain have developed a highly sensitive method to
Body The traditional model of the doctor–patient relationship is being challenged. This relationship is generally asymmetric in terms of power—the doctor asks the patient questions
Bone-marrow-derived mesenchymal stem cells can suppress orofacial pain rapidly — within one day of treatment — by either IV injection of cells or direct injection